KalVista Pharmaceuticals, Inc. has announced the granting of inducement stock options to five newly-hired employees as part of their compensation package. These options allow the purchase of a total of 23,000 shares of the company's common stock, effective from July 1, 2025. The exercise price for these options is set at the closing price of KalVista's stock on the grant date. The vesting schedule includes one-fourth of the options becoming available one year from the vesting commencement date, with the remaining options vesting in equal monthly installments over the following three years, contingent upon continued employment. Each option has a 10-year term and adheres to the guidelines of KalVista's Inducement Equity Incentive Plan. These grants were made under Nasdaq Listing Rule 5635(c)(4).